A lab scientist peering into a microscope focused on gene editing technology. Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a ...

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

This animation includes a gene being edited using CRISPR technology. CRISPR-Cas9 proteins recognize and cut foreign pathogenic DNA CRISPR-Cas9 proteins recognize and cut foreign pathogenic DNA crispr ...

Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, thanks to the FDA approval of its one-shot gene therapy Casgevy for two ...

CRISPR Therapeutics AG (CRSP) stock price is 41.21 and CRISPR Therapeutics AG (CRSP) 10-day simple moving average is 41.52. CRISPR Therapeutics AG (CRSP) stock price is 41.21 and CRISPR ...

Jim Cramer, the host of Mad Money, reflected on the uncertainty surrounding the year 2025, focusing on several macroeconomic ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In ... that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...

GMO DNA video. 4K Biology and science animation footage mitosis microscope stock videos & royalty-free footage stem cell immunotherapy research DNA gene therapy CRISPR... stem cell immunotherapy ...

The most recent trading session ended with CRISPR Therapeutics AG (CRSP) standing at $38.36, reflecting a -1.26% shift from the previouse trading day's closing. The stock trailed the S&P 500 ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.